Skip to main navigation Skip to search Skip to main content

Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses

  • Anusha Nathan
  • , Elizabeth J. Rossin
  • , Clarety Kaseke
  • , Ryan J. Park
  • , Ashok Khatri
  • , Dylan Koundakjian
  • , Jonathan M. Urbach
  • , Nishant K. Singh
  • , Arman Bashirova
  • , Rhoda Tano-Menka
  • , Fernando Senjobe
  • , Michael T. Waring
  • , Alicja Piechocka-Trocha
  • , Wilfredo F. Garcia-Beltran
  • , A. John Iafrate
  • , Vivek Naranbhai
  • , Mary Carrington
  • , Bruce D. Walker
  • , Gaurav D. Gaiha

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape convalescent and vaccine-induced antibody responses has renewed focus on the development of broadly protective T-cell-based vaccines. Here, we apply structure-based network analysis and assessments of HLA class I peptide stability to define mutationally constrained CD8+ T cell epitopes across the SARS-CoV-2 proteome. Highly networked residues are conserved temporally among circulating variants and sarbecoviruses and disproportionately impair spike pseudotyped lentivirus infectivity when mutated. Evaluation of HLA class I stabilizing activity for 18 globally prevalent alleles identifies CD8+ T cell epitopes within highly networked regions with limited mutational frequencies in circulating SARS-CoV-2 variants and deep-sequenced primary isolates. Moreover, these epitopes elicit demonstrable CD8+ T cell reactivity in convalescent individuals but reduced recognition in recipients of mRNA-based vaccines. These data thereby elucidate key mutationally constrained regions and immunogenic epitopes in the SARS-CoV-2 proteome for a global T-cell-based vaccine against emerging variants and SARS-like coronaviruses.

Original languageEnglish
Pages (from-to)4401-4413.e10
Number of pages24
JournalCell
Volume184
Issue number17
DOIs
Publication statusPublished - 19 Aug 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CD8 T cells
  • COVID-19
  • epitopes
  • protection
  • sarbecovirus
  • SARS-CoV-2
  • vaccine
  • variants

Cite this